Valion Bio inaugurated its new biomanufacturing subsidiary, Velocity Bioworks, in San Antonio, enhancing its ability to produce Entolimod, a drug for radiation syndrome and cancer care. The facility supports the company's strategy for secure, domestic production and national preparedness, with backing from U.S. government agencies. Velocity Bioworks also aims to serve third-party biotech clients, positioning Valion Bio as a key player in biomanufacturing. This development strengthens the regional bioscience economy and advances treatments for cancer patients and U.S. warfighters.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Alpaca, a brokerage infrastructure startup, secured $435 million in funding to enter prime brokerage services, challenging traditional Wall Street firms. The company’s API supports 94% of US equities and powers tokenized stocks for Kraken. Alpaca’s t...
Raymond James Financial's rating was raised to "Buy" after positive investor event disclosures and a promising preview of its upcoming quarterly results. The company is expected to exceed earnings per share consensus for Q3 FY26, driven by strong per...
Whales have accumulated 70 million XRP over the past week, showing strong confidence despite XRP's price consolidating below resistance levels. The XRP Ledger surpassed 8 million activated accounts, indicating growing network adoption across payments...
Bunker Hill Mining Corp. has appointed Bradley Barnett as permanent CFO and Mark Hayes as General Counsel to support its transition to commercial production at the historic Bunker Hill Mine in Idaho. The company also achieved an improved 'A' grade in...
